| Literature DB >> 22672435 |
Ainslie M Hildebrand1, Arthur V Iansavichus, Christopher W C Lee, R Brian Haynes, Nancy L Wilczynski, K Ann McKibbon, Michelle A Hladunewich, William F Clark, Daniel C Cattran, Amit X Garg.
Abstract
BACKGROUND: Tools to enhance physician searches of Medline and other bibliographic databases have potential to improve the application of new knowledge in patient care. This is particularly true for articles about glomerular disease, which are published across multiple disciplines and are often difficult to track down. Our objective was to develop and test search filters for PubMed, Ovid Medline, and Embase that allow physicians to search within a subset of the database to retrieve articles relevant to glomerular disease.Entities:
Mesh:
Year: 2012 PMID: 22672435 PMCID: PMC3471011 DOI: 10.1186/1472-6947-12-49
Source DB: PubMed Journal: BMC Med Inform Decis Mak ISSN: 1472-6947 Impact factor: 2.796
Two by two contingency table comparing filter to ‘reference standard’
| Article identified | a | b |
| Article not identified | c | d |
Sensitivity = a/(a + c): proportion of all articles with information on glomerular disease in the reference set that are retrieved by the filter (also called recall in information retrieval studies).
Specificity = d/(b + d): proportion of all articles without information on glomerular disease in the reference set that are correctly not retrieved by the filter.
Precision = a/(a + b): proportion of all articles retrieved by the filter with information on glomerular disease (also referred to as positive predictive value in diagnostic test terminology).
Accuracy = (a + d)/(a + b + c + d): proportion of all articles dealt with correctly by filter.
Glomerular Disease Search Filters for PubMed, Ovid Medline, and Embase Optimized for High Sensitivity and High Specificity
| | ||||||
|---|---|---|---|---|---|---|
| PubMed Filters‡ | ||||||
| High-Sensitivity Filter | (nephropath*[tw] OR glomerulonephrit*[tw] OR proteinuri*[tw] OR nephrotic[tw] OR glomerulosclerosis[tw] OR nephrit*[tw] OR kidney biopsy[tiab] OR renal biopsy[tiab] OR albuminuri*[tw] OR glomerulopath*[tiab] OR membranoproliferative[tw] OR mesangioproliferative[tiab] OR nephrosis[tw] OR microalbuminuri*[tiab] OR diabetic kidney[tw] OR diabetic renal[tw] OR anti-glomerular[tw] OR nephrosclerosis[tiab] OR alport*[tw] OR goodpasture*[tiab] OR minimal change[tiab] OR glomerular disease*[tiab] OR anca*[tw] OR anti-neutrophil[tw] OR polyangiitis[tw] OR polyangitis[tw] OR antineutrophil[tw] OR antiglomerular[tw] OR "Kidney Glomerulus"[majr:noexp] OR "Lupus Erythematosus, Systemic"[majr:noexp] OR "Vasculitis"[majr:noexp] OR "Purpura, Schoenlein-Henoch"[mh:noexp] OR "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis"[mh] OR ((lupus[tw] OR vasculitis[tw] OR purpura[tw] OR granulomatosis[tw]) AND (glomerul*[tw] OR kidney[tw] OR renal[tw] OR nephrolog*[tw])) OR ((chronic kidney[tiab] OR chronic renal[tiab] OR "Renal Insufficiency, Chronic"[mh]) AND ("Diabetes Mellitus, Type 2"[majr:noexp] OR "Kidney Glomerulus"[mh:noexp])) OR ("Kidney Diseases"[majr] AND (biopsy[tw] OR myeloma[tiab] OR renin-angiotensin[tw] OR hiv[tiab] OR amyloid*[tw]))) | Development | 96.7 (95.1-98.3) | 95.2 (94.9-95.6) | 43.4 (40.4-46.3) | 95.3 (94.9-95.7) |
| | | Validation | 94.8 (91.1-98.6) | 96.0 (95.5-96.4) | 28.5 (24.3-32.7) | 95.9 (95.5-96.4) |
| High-Specificity Filter | (glomerulonephrit*[tw] OR nephrotic[tw] OR diabetic nephropath*[tw] OR glomerulosclerosis[tw] OR iga nephropath*[tiab] OR minimal change[tiab] OR membranoproliferative[tw] OR glomerulopath*[tiab] OR membranous nephropathy[tiab] OR antineutrophil[tw] OR nephrosis[tw] OR anca*[tw] OR diabetic kidney[tiab] OR anti-glomerular[tw] OR glomerular disease*[tiab] OR anti-neutrophil[tw] OR antiglomerular[tw] OR polyangiitis[tw] OR alport*[tw] OR mesangioproliferative[tiab] OR goodpasture*[tiab] OR immunoglobulin a nephropathy[tiab] OR "AIDS-Associated Nephropathy"[majr:noexp] OR "Purpura, Schoenlein-Henoch"[majr:noexp] OR "Nephritis, Hereditary"[majr:noexp] OR "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis"[majr] OR "Balkan Nephropathy"[majr:noexp] OR (diabet*[ti] AND nephropath*[ti]) OR ((kidney[tw] OR renal[tw] OR nephrit*[tw] OR nephrolog*[tw] OR glomerul*[tw]) AND (purpura[tw] OR lupus[tw] OR vasculitis[tw])) OR ((nephrit*[tw] OR "Renal Insufficiency, Chronic"[mh] OR chronic kidney[tiab] OR chronic renal[tiab]) AND ("Kidney Glomerulus"[mh:noexp] OR "Diabetes Mellitus, Type 2"[majr:noexp] OR microalbuminuri*[tiab] OR immunoglobulin[tiab])) OR ((proteinuri*[ti] OR "Proteinuria"[majr:noexp]) AND (hematuria[tw] OR haematuria[tiab] OR glomerulo*[tw] OR amyloid*[tw] OR albuminuri*[tiab] OR inflammation[tiab] OR myeloma[tw])) OR ((glomerulo*[tw] OR nephropath*[tiab] OR proteinuri*[ti] OR microalbuminuri*[ti] OR albuminuri*[ti]) AND ("Diabetes Mellitus, Type 2"[majr:noexp] OR "Diabetic Angiopathies"[majr] OR overt[tiab])) OR ("Kidney Diseases"[majr:noexp] AND (amyloid*[tw] OR mesangio*[tiab] OR sclerosis[tiab]))) | Development | 93.8 (91.6-95.9) | 98.4 (98.2-98.6) | 69.2 (65.6-72.7) | 98.3 (98.0-98.5) |
| | | Validation | 91.1 (86.3-95.9) | 98.5 (98.2-98.7) | 50.4 (44.1-56.7) | 98.4 (98.1-98.6) |
| Medline Filters† | ||||||
| High-Sensitivity Filter | (nephropath$.mp OR glomerulonephrit$.mp OR proteinuri$.mp OR nephrotic.mp OR glomerulosclerosis.mp OR nephrit$.mp OR renal biopsy.tw OR albuminuri$.mp OR minimal change.tw OR glomerulopath$.tw OR membranoproliferative.mp OR antineutrophil.mp OR glomerular disease$.tw OR nephrosis.mp OR microalbuminuri$.tw OR anca$.mp OR (diabetic adj (kidney or renal)).mp OR kidney biopsy.tw OR anti-glomerular.mp OR antiglomerular.mp OR anti-neutrophil.mp OR polyang?itis.mp OR alport$.mp OR mesangioproliferative.tw OR goodpasture$.tw OR nephrosclerosis.tw OR *Kidney Glomerulus/ OR *Lupus Erythematosus, Systemic/ OR *Vasculitis/ OR Purpura, Schoenlein-Henoch/ OR exp Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/ OR ((glomerul$.mp OR kidney.mp OR renal.mp OR nephrolog$.mp) AND (lupus.mp OR purpura.mp OR vasculitis.mp OR granulomatosis.mp)) OR ((chronic adj2 (kidney or renal)).mp AND (*Diabetes Mellitus, Type 2/ OR Kidney Glomerulus/)) OR (exp *Kidney Diseases/ AND (biopsy.mp OR myeloma.tw OR renin-angiotensin.mp OR hiv.tw OR amyloid$.mp))) | Development | 96.7 (95.1-98.3) | 95.2 (94.9-95.6) | 43.4 (40.4-46.3) | 95.3 (94.9-95.6) |
| | | Validation | 94.8 (91.1-98.6) | 96.0 (95.5-96.4) | 28. 6 (24.4-32.8) | 96.0 (95.5-96.4) |
| High-Specificity Filter | (glomerulonephrit$.mp OR (diabetic adj (nephropath$ or kidney)).mp OR nephrotic.mp OR glomerulosclerosis.mp OR iga nephropath$.tw OR minimal change.tw OR glomerulopath$.tw OR membranous nephropathy.tw OR membranoproliferative.mp OR antineutrophil.mp OR glomerular disease$.tw OR nephrosis.mp OR anca$.mp OR anti-glomerular.mp OR anti-neutrophil.mp OR antiglomerular.mp OR polyang?itis.mp OR alport$.mp OR mesangioproliferative.tw OR goodpasture$.tw OR immunoglobulin a nephropathy.tw OR *AIDS-Associated Nephropathy/ OR *Purpura, Schoenlein-Henoch/ OR *Nephritis, Hereditary/ OR exp *Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/ OR *Balkan Nephropathy/ OR (diabet$ AND nephropath$).ti OR ((glomerul$.mp OR kidney.mp OR renal.mp OR nephrit$.mp OR nephrolog$.mp) AND (lupus.mp OR vasculitis.mp OR purpura.mp)) OR ((nephrit$ OR (chronic adj2 (kidney or renal))).mp. AND (Kidney Glomerulus/ OR *Diabetes Mellitus, Type 2/ OR microalbuminuri$.tw. OR immunoglobulin.tw.)) OR ((proteinuri$.ti OR *Proteinuria/) AND (glomerulo$.mp OR h?ematuria.mp OR albuminuri$.tw OR inflammation.tw OR amyloid$.mp OR myeloma.mp)) OR ((glomerulo$.mp OR nephropath$.tw OR proteinuri$.ti OR microalbuminuri$.ti OR albuminuri$.ti) AND (*Diabetes Mellitus, Type 2/ OR exp *Diabetic Angiopathies/ OR overt.tw)) OR (*Kidney Diseases/ AND (amyloid$.mp OR mesangio$.tw OR sclerosis.tw))) | Development | 93.8 (91.6-95.9) | 98.4 (98.2-98.6) | 69.2 (65.6-72.7) | 98.3 (98.0-98.5) |
| | | Validation | 91.1 (86.3-95.9) | 98.5 (98.2-98.8) | 50.6 (44.3-56.9) | 98.4 (98.1-98.6) |
| Embase Filters∫ | ||||||
| High-Sensitivity Filter | (exp glomerulopathy/ OR ((kidney or renal) adj biopsy).mp OR (diabet$ adj (kidney or renal or nephr$)).mp OR nephrotic.tw OR nephrotic syndrome/ OR glomerulonephrit$.tw OR immunoglobulin a nephropathy/ OR glomerul$ basement membrane$.mp OR iga nephropath$.tw OR minimal change.mp OR membranoproliferative.mp OR (glomerul$ adj (nephr$ or disease$ or scleros$)).tw OR membranous nephr$.tw OR anca$.mp OR proliferative glomerulonephritis/ OR wegener granulomatosis/ OR antineutrophil.mp OR polyang?itis.mp OR *glomerulus/ OR anaphylactoid purpura/ OR alport$.mp OR hiv-associated nephropath$.tw OR anti-neutrophil.mp OR mesangioproliferative.mp OR goodpasture$.mp OR (balkan adj2 nephr$).mp OR heymann nephritis/ OR ((lupus.mp OR vasculit$.mp OR purpur$.mp OR hiv$.tw OR granulomatosis.mp) AND ("Urology and nephrology".ec OR proteinuri$.mp OR nephrit$.mp)) OR ((exp *diabetes mellitus/ OR diabet$.ti) AND (nephropath$.tw OR exp *proteinuria/ OR renin-angiotensin$.mp OR dialys$.tw OR *kidney failure/ OR ((kidney OR renal) adj disease$).ti OR h?emodialys$.tw)) OR (exp *kidney disease/ AND (nephropath$.ti OR exp *proteinuria/ OR renin-angiotensin$.mp OR proteinuri$.ti OR amyloid$.mp)) OR ((exp proteinuria/ OR proteinuri$.mp) AND (nephropath$.tw OR nephrit$.mp OR renin-angiotensin$.tw))) | Development | 9.0 (98.1-99.9) | 95.3 (94.9-95.6) | 43.4 (40.5-46.3) | 95.4 (95.1-95.8) |
| | | Validation | 96.4 (93.3-99.5) | 96.0 (95.6-96.4) | 29.4 (25.2-33.4) | 96.0 (95.6-96.4) |
| High-Specificity Filter | (exp *glomerulopathy/ OR nephrotic.tw OR glomerulonephrit$.tw OR diabetic nephropath$.tw OR *diabetic nephropathy/ OR glomerul$ basement membrane$.mp OR nephrotic syndrome/ OR *immunoglobulin a nephropathy/ OR iga nephropath$.tw OR minimal change.mp OR membranoproliferative.tw OR membranous nephropathy.tw OR anca$.mp OR proliferative glomerulonephritis/ OR antineutrophil.mp OR polyang?itis.mp OR *glomerulus/ OR alport$.mp OR hiv-associated nephropath$.tw OR anti-neutrophil.mp OR *anaphylactoid purpura/ OR *wegener granulomatosis/ OR goodpasture$.tw OR mesangioproliferative.tw OR (balkan adj2 nephr$).tw OR ((lupus.mp OR vasculit$.tw OR granulomatosis.mp OR purpur$.tw OR amyloid$.tw) AND (kidney biopsy/ OR proteinuri$.mp OR nephrit$.mp OR serum creatinine.tw)) OR ((exp *diabetes mellitus/ OR proteinuri$.ti OR *proteinuria/) AND (exp glomerulopathy/ OR nephropath$.tw OR *kidney failure/ OR ((kidney or renal) adj disease$).ti OR *microalbuminuria/)) OR ((exp glomerulopathy/ OR diabetic nephropath$.mp) AND (kidney biopsy/ OR mesangial$.tw OR angiotensin$.tw OR serum creatinine.tw OR albuminuri$.mp OR microalbuminuri$.mp))) | Development | 95.7 (93.9-97.5) | 98.6 (98.4-98.8) | 71.1 (67.6-74.6) | 98.5 (98.3-98.7) |
| Validation | 92.8 (88.5-97.1) | 98.6 (98.3-98.8) | 52.9 (46.6-59.1) | 98.5 (98.2-98.7) | ||
‡ PubMed fields: * = truncation character; [tw] = text word present in title, abstract, or MeSH term; [tiab] = term present in title or abstract; [majr:noexp] = not exploded and focused MeSH term; [mh:noexp] = non-exploded MeSH term; [mh] = exploded MeSH term; [majr] = exploded and focused MeSH term; [ti] = term present in title.
† Medline fields: $ = truncation character; mp = multiple posting (term appears in title, abstract, or MeSH); tw = text word present in title; /=MeSH character; adj = adjacent operator; * = focused MeSH term; adj2 = defined adjacency operator; exp = exploded MeSH term; ? = optional wildcard; ti = term present in title.
∫ Embase fields: exp = exploded EMTREE term; /=EMTREE character; adj = adjacent operator; $ = truncation character; mp = multiple posting (term appears in title, abstract, or EMTREE); tw = term present in title or abstract; * = focused EMTREE term; adj2 = defined adjacency operator; ec = Embase section headings field; ti = term present in title.
Proof-of-concept searches showing the number of relevant articles retrieved with and without glomerular disease filter
| What are the efficacy and safety of mycophenolate mofetil (MMF) and cyclophosphamide (CYC) in the treatment of proliferative lupus glomerulonephritis (GN)? (7 relevant articles) [ | 2006 | 7 | 1721 | 7 | 1080 | 7 |
| Is immunosuppressive treatment effective and safe in the treatment of idiopathic membranous nephropathy (IMN) in adults with nephrotic syndrome? (15 relevant articles) [ | 87500 | 15 | 3231 | 15 | 2687 | 15 |
| Does corticosteroid therapy ameliorate the acute manifestations of Henoch-Schonlein purpura or mitigate renal injury? (15 relevant articles) [ | 393 | 5 | 68 | 5 | 65 | 5 |
| What are the benefits and harms of different interventions for the treatment of renal vasculitis in adults? (13 relevant articles) [ | 34741 | 8 | 8455 | 8 | 5923 | 8 |
| What is the effect of a low-protein diet (LPD) on renal function in patients with type 1 or 2 diabetic renal diseases? (8 relevant articles) [ | 868 | 7 | 207 | 7 | 180 | 6 |
| What are the benefits and harms of interventions for the nephrotic syndrome in adults caused by minimal change disease? (3 relevant articles) [ | 4662 | 3 | 1236 | 3 | 1203 | 3 |
* The search phrases as determined and typed in by physicians were: ‘(mycophenolate OR cyclophosphamide) lupus’, ‘treatment membranous’, ‘steroid HSP’, ‘renal vasculitis treatment limit to english, core journals, adults’, ‘low protein diet diabetes’, and ‘minimal change treatment’.